Treatment Patterns for Calcitonin Gene-Related Peptide Monoclonal Antibodies Including Galcanezumab versus Conventional Preventive Treatments for Migraine: A Retrospective US Claims Study

Treatment Patterns for Calcitonin Gene-Related Peptide Monoclonal Antibodies Including Galcanezumab versus Conventional Preventive Treatments for Migraine: A Retrospective US Claims Study

Oralee J Varnado,1 Janna Manjelievskaia,2 Wenyu Ye,1 Allison Perry,2 Kory Schuh,1 Richard Wenzel1 1Value, Evidence, and Outcomes, Eli Lilly and Company, Indianapolis, IN, USA; 2Watson Health Life Sciences, Research & Analytics, IBM Watson Health, Cambridge, MA, USACorrespondence: Oralee J Varnad...

Full description

Bibliographic Details
Main Authors: Varnado OJ, Manjelievskaia J, Ye W, Perry A, Schuh K, Wenzel R
Format: Article
Language:English
Published: Dove Medical Press 2022-03-01
Series:Patient Preference and Adherence
Subjects:
cgrp
persistence
adherence
discontinuation
switch.
Online Access:https://www.dovepress.com/treatment-patterns-for-calcitonin-gene-related-peptide-monoclonal-anti-peer-reviewed-fulltext-article-PPA

Internet

https://www.dovepress.com/treatment-patterns-for-calcitonin-gene-related-peptide-monoclonal-anti-peer-reviewed-fulltext-article-PPA

Similar Items